| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.874 | 46.073 | 61.700 | 114.510 | 168.761 | 193.930 | 256.292 | 286.033 | 362.660 |
| Total Income - EUR | - | 2.874 | 46.073 | 61.700 | 114.513 | 173.068 | 244.077 | 282.463 | 287.101 | 404.150 |
| Total Expenses - EUR | - | 2.711 | 20.961 | 39.260 | 95.200 | 132.586 | 173.342 | 222.812 | 228.951 | 336.273 |
| Gross Profit/Loss - EUR | - | 163 | 25.113 | 22.440 | 19.312 | 40.482 | 70.735 | 59.650 | 58.150 | 67.877 |
| Net Profit/Loss - EUR | - | 135 | 24.652 | 21.823 | 18.167 | 39.159 | 68.344 | 56.893 | 55.719 | 55.990 |
| Employees | - | 2 | 2 | 2 | 5 | 7 | 7 | 9 | 10 | 12 |
Check the financial reports for the company - Neuro Diamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 734 | 641 | 251.535 | 387.404 | 349.654 | 396.009 | 396.329 | 338.856 | 294.591 |
| Current Assets | - | 2.829 | 25.746 | 5.080 | 7.431 | 15.905 | 20.230 | 30.322 | 51.269 | 66.397 |
| Inventories | - | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.562 |
| Receivables | - | 2.651 | 17.269 | 4.196 | 4.990 | 2.585 | 14.337 | 18.542 | 41.710 | 0 |
| Cash | - | 176 | 8.477 | 884 | 2.441 | 13.320 | 5.893 | 11.780 | 9.559 | 46.835 |
| Shareholders Funds | - | 179 | 24.828 | 21.875 | 18.218 | 39.209 | 68.392 | 56.942 | 112.488 | 167.849 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.384 | 1.559 | 234.741 | 376.617 | 326.350 | 347.846 | 369.709 | 277.636 | 193.138 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Diamed Srl